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Dear Editors
Elevated obesity rates are a major contributor to the dramatic gap in life expectancy affecting 
people with serious mental illness (SMI) (Allison et al., 2009). Recent trials of lifestyle 
interventions targeting this group have achieved modest weight loss of ≥5% in upwards of 
47% of participants, or reduced cardiovascular risk in roughly half of participants (Bartels et 
al., 2013; Bartels et al., 2015; Daumit et al., 2013; Green et al., 2015). Despite the promise 
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of these interventions, many are resource intensive, and there remain considerable barriers to 
implementation in real world settings.
In contrast, the Diabetes Prevention Program (DPP) in the general population is the most 
widely replicated model for behavioral weight loss in the United States (Ali et al., 2012). 
The DPP focuses on achieving ≥7% weight loss through a healthy low-calorie, low-fat diet, 
and increasing physical activity to 150 min each week. The DPP trial, in which half of 
participants receiving the lifestyle intervention achieved over 7% weight loss (Diabetes 
Prevention Program Research Group, 2002), and subsequent Look AHEAD (Action for 
Health in Diabetes) trial, in which over 55% of participants receiving the intensive lifestyle 
intervention modeled after the DPP achieved over 7% weight loss (The Look AHEAD 
Research Group, 2007), are considered gold standards in behavioral weight management 
research.
In spite of the high prevalence of obesity among people with SMI (Allison et al., 2009), both 
the DPP and Look AHEAD trials systematically excluded people with schizophrenia, other 
psychotic disorders, bipolar disorder, hospitalization for depression in the past six months, 
self-reported psychiatric hospitalization, use of psychoactive medications, or other 
psychiatric or behavioral factors that could interfere with compliance, study participation, or 
ability to follow the intervention protocol (Diabetes Prevention Program Research Group, 
2001; The Look AHEAD Research Group, 2012). The exclusion of people with SMI is 
consistent across most large weight loss studies due to challenges in achieving weight loss in 
this group, such as metabolic effects of psychoactive medications, impact of symptoms on 
motivation and ability to complete the studies, and consequences of poverty, low health 
literacy, societal stigma of having a mental illness, and social isolation on study retention 
(Allison et al., 2009).
Identifying differences in these target populations may highlight specific considerations for 
tailoring scalable and economically sustainable lifestyle interventions developed for the 
general population for adults with SMI or provide insights for scaling existing intensive 
weight loss interventions targeting this group. We compared characteristics of N = 465 
participants with SMI enrolled in three trials of the evidenced-based In SHAPE lifestyle 
intervention with those of N = 3234 participants enrolled in the DPP and N = 5145 
participants enrolled in the Look AHEAD trials in the general population.
1. In SHAPE program
The 12-month In SHAPE lifestyle intervention consists of a gym membership and weekly 
individual meetings with a certified fitness trainer who helps participants develop 
personalized fitness plans, provides fitness coaching, instruction on healthy eating, and 
support for managing mental health symptoms that interfere with exercise and healthy eating 
(Bartels et al., 2013; Bartels et al., 2015). Between 2007 and 2013, N = 465 participants with 
SMI were enrolled across three trials (2 in New Hampshire, and 1 in Boston, MA) of the In 
SHAPE program delivered in community mental health settings. Inclusion and exclusion 
criteria are reported elsewhere (Bartels et al., 2013; Bartels et al., 2015). Study procedures 
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were approved by Committees for the Protection of Human Subjects at Dartmouth College 
and specific to each site.
2. Findings and implications
Table 1. compares baseline characteristics of participants in the In SHAPE trials with those 
of participants in the DPP and Look AHEAD trials. The proportion of participants in the In 
SHAPE trials with annual household income under $25,000 was nearly 6 times greater, with 
less than 13 years of education was about double, who were unemployed was 8 to 17 times 
greater, and who were never married was up to 8 times greater. Participants with SMI were 
at increased cardiovascular risk, with rates of smoking 5 to 8 times higher and severe obesity 
1.5 to 2 times higher compared to DPP and Look AHEAD trial participants.
These findings illustrate many of the challenges for implementing and scaling behavioral 
weight loss interventions targeting this group. To date, effective behavioral weight loss in 
people with SMI has been resource-intensive and has required individualized support and 
counseling, often in combination with supported exercise or group nutrition education. 
Providing additional support increases costs and limits intervention scalability, but is likely 
necessary for overcoming the combined effects of socioeconomic instability and mental 
health symptoms that contribute to low-motivation, poor functioning, and social isolation. 
By contrast, lower intensity interventions of short duration have shown limited effectiveness 
in this group, as they likely are insufficient for overcoming these health disparities and 
complex social factors.
Future efforts must focus on increasing intervention reach without sacrificing impact or 
effectiveness. Successes of the DPP and Look AHEAD trials offer valuable insights for 
informing the dissemination of weight loss programs targeting people with SMI. Through 
new collaborations between mental health services researchers and behavioral scientists, 
existing behavioral weight loss interventions tailored to meet the needs of this at-risk group 
could incorporate components of successful programs delivered in the general population to 
lower costs and increase scalability. Continued efforts across medicine and social science 
disciplines are needed to address this serious public health concern in the form of 
significantly reduced life expectancy affecting people with SMI.
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